Prime Medicine (PRME) Accounts Payables (2021 - 2025)
Historic Accounts Payables for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $9.4 million.
- Prime Medicine's Accounts Payables rose 7229.69% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 7229.69%. This contributed to the annual value of $11.4 million for FY2024, which is 4190.0% down from last year.
- Prime Medicine's Accounts Payables amounted to $9.4 million in Q3 2025, which was up 7229.69% from $6.4 million recorded in Q2 2025.
- In the past 5 years, Prime Medicine's Accounts Payables registered a high of $19.5 million during Q4 2023, and its lowest value of $1.4 million during Q4 2021.
- Its 5-year average for Accounts Payables is $7.9 million, with a median of $5.9 million in 2023.
- In the last 5 years, Prime Medicine's Accounts Payables soared by 35099.26% in 2023 and then tumbled by 6156.19% in 2024.
- Quarter analysis of 5 years shows Prime Medicine's Accounts Payables stood at $1.4 million in 2021, then soared by 201.88% to $4.3 million in 2022, then surged by 350.99% to $19.5 million in 2023, then crashed by 41.9% to $11.4 million in 2024, then decreased by 17.59% to $9.4 million in 2025.
- Its Accounts Payables stands at $9.4 million for Q3 2025, versus $6.4 million for Q2 2025 and $10.0 million for Q1 2025.